Lumida
/AGX
⌘K
Argan Inc

Argan Inc

AGX
$413.74USD+4.39%+17.41 today

MARKET CAP

5.8B

P/E (TTM)

42.5x

FWD P/E

DAY RANGE

$401 – $417

52W RANGE

$227
$806

AI Summary

Stalk
StalkMedium

AGX is in a pronounced Stage 4 decline, trading well below all major EMAs yet registering extreme oversold readings that qualify for mean-reversion; while the double bottom and bearish exhaustion patterns suggest a potential reversal foundation, execution should be deferred until price shows clear acceptance above short-term EMAs or holds near the defended low support zone.

  • Revenue up 50% YoY to $291M in Q1 FY27, exceeding expectations.
  • Backlog of $2.8B with guidance to add new projects over next 10–18 months.
  • Valuation metrics indicate overvaluation risk for value-focused investors.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2022FY 2023FY 2024FY 2025FY 2026TREND
Sales, Adj.$509.4M$455.0M$573.3M$874.2M$944.6M
YoY %+29.9%-10.7%+26.0%+52.5%+8.1%
P / Sales1.2x1.2x1.0x2.2x5.3x
EV / Sales0.9x1.3x1.2x2.6x5.7x
Gross Profit, Adj.$99.7M$86.4M$80.8M$141.0M$193.7M
YoY %+60.7%-13.4%-6.4%+74.4%+37.4%
Margin %19.6%19.0%14.1%16.1%20.5%
EV / Gross Profit4.7x6.8x8.8x15.9x28.0x
EBITDA, Adj.$56.6M$44.7M$38.5M$90.1M$136.6M
YoY %+104.9%-21.2%-13.8%+134.2%+51.6%
Margin %11.1%9.8%6.7%10.3%14.5%
EV / EBITDA8.3x13.2x18.5x24.9x39.7x
EBIT$44.5M$41.7M$36.5M$88.2M$134.7M
YoY %+93.3%-6.4%-12.5%+141.9%+52.7%
Margin %8.7%9.2%6.4%10.1%14.3%
EV / EBIT10.5x14.1x19.5x25.4x40.2x
Net Income$38.2M$33.1M$32.4M$85.5M$137.8M
YoY %+60.3%-13.5%-2.2%+164.1%+61.2%
Net Margin7.5%7.3%5.6%9.8%14.6%
EPS (GAAP)$2.40$2.33$2.39$6.15$9.74
YoY %+58.9%-2.9%+2.6%+157.3%+58.4%